Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Landos Biopharma Inc (LABP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2021	06-2021	03-2021	12-2020	09-2020
Cash Flows From Operating Activities
Net Income	-18,325	-5,721	-9,818	-30,144	-18,803
Depreciation Amortization	1,351	338	-153	137	185
Accounts payable and accrued liabilities	1,505	2,067	-404	6,506	4,179
Other Working Capital	398	458	-3,612	5,881	4,006
Other Operating Activity	67	-302	1,427	-5,342	-4,138
Operating Cash Flow	$-15,004	$-3,160	$-12,560	$-22,962	$-14,571

Cash Flows From Investing Activities
PPE Investments	-477	-213	-64	-181	-91
Purchase Of Investment	-165,914	-85,409	-81,379	-21,718	-14,423
Sale Of Investment	105,889	14,289	9,395	36,030	21,715
Investing Cash Flow	$-60,502	$-71,333	$-72,048	$14,131	$7,201

Cash Flows From Financing Activities
Common Stock Issued	90,983	90,764	90,764	1,518	N/A
Financing Cash Flow	$90,983	$90,764	$90,764	$1,518	$N/A

Exchange Rate Effect	N/A	N/A	N/A	-79	39
Beginning Cash Position	2,416	2,416	2,416	9,808	9,808
End Cash Position	17,893	18,687	8,572	2,416	2,477
Net Cash Flow	$15,477	$16,271	$6,156	$-7,392	$-7,331

Free Cash Flow
Operating Cash Flow	-15,004	-3,160	-12,560	-22,962	-14,571
Capital Expenditure	-477	-213	-64	-181	-91
Free Cash Flow	-15,481	-3,373	-12,624	-23,143	-14,662